Related Experiment Video
Updated: May 28, 2026

Real-Time Monitoring and Modulation of Blood Pressure in a Rabbit Model of Ischemic Stroke
Published on: February 10, 2023
Hypertension as a risk factor: is it different in ischemic stroke and acute myocardial infarction comparative
Zaki Noah Hasan1, Mousa Qasim Hussein, Ghazi Farhan Haji
1Department of Neurology, Al-kindy College of Medicine, Baghdad University, Box 47188 Jadiryah, Baghdad, Iraq.
Insights
Patients with myocardial infarction showed higher noncompliance with antihypertensive therapy and salt-free diets compared to stroke patients. Silent hypertension was prevalent in both groups, particularly in stroke patients.
Area of Science:
- Cardiology
- Neurology
- Public Health
Background:
- Hypertension is a major risk factor for both stroke and myocardial infarction.
- Understanding patient compliance with treatment and diet is crucial for managing cardiovascular diseases.
- Limited data exists on comparative compliance between stroke and myocardial infarction patients in Iraq.
Purpose of the Study:
- To compare age of onset, hypertension duration, drug types, and compliance with antihypertensive therapy and salt-free diets.
- To identify differences in these factors between patients who have experienced stroke and those who have had myocardial infarction.
Main Methods:
- A comparative study conducted in three hospitals in Baghdad from June 2010 to June 2011.
- Inclusion of 81 stroke patients (33-82 years) and 110 myocardial infarction patients (23-76 years).
- Data collection on patient demographics, hypertension history, medication adherence, and dietary compliance.
Main Results:
- Salt-free diet noncompliance was high in both groups (69% for myocardial infarction, 62% for stroke).
- Silent hypertension was more prevalent in the stroke group (19.7%) compared to the myocardial infarction group (6.3%).
- Drug noncompliance was significantly higher in myocardial infarction patients (71%) than in stroke patients (48%).
- Angiotensin Converting Enzyme Inhibitors were the most common drug class in both groups.
- Angiotensin II receptor blocker use was significantly associated with myocardial infarction more than stroke.
Conclusions:
- Silent hypertension and noncompliance with salt-free diets are significant issues in Iraq.
- Myocardial infarction patients demonstrated higher noncompliance with antihypertensive therapy compared to stroke patients.
- Specific antihypertensive drug usage patterns differ between stroke and myocardial infarction cohorts.
Abstract:
Objective. To assess differences in age of onset, hypertension duration, type of drug, treatment compliance, and salt-free diet compliance between patients with stroke and myocardial infarction. Patients and Methods. The study was conducted in 3 hospitals in Baghdad between June 2010 and June 2011. First group includes 81 stroke patients (36 females and 45 males), age ranges between (33-82 years). Second group includes 110 myocardial infarction patients (46 females and 64 males), ages ranges from (23-76 years). Results. Salt-free diet noncompliance was seen in 69% and 62% of Myocardial infarction and stroke groups, respectively. Silent hypertension was seen in 6.3% and 19.7% of myocardial infarction and stroke groups, respectively. Noncompliant on antihypertensive therapy was seen in 61%, 71%, and 48% of the total, myocardial infarction, and stroke groups, respectively. The drug type was 24% angiotensin converting enzyme inhibitor, 18.8% combined drugs, 16.2% Beta Blocker, 11% angiotensin 11 receptor blocker, 10.4% calcium channel blocker and 7.3% diuretic. In stroke group, the commonest drug was 23% angiotensin converting inhibitor and the least (5%) was angiotensin receptor blocker. In myocardial infarction group, the commonest drug was 25% Angiotensin Converting Inhibitor and the least (8%) was diuretic. Discussion and Conclusion. Silent hypertension was high in Iraq. Salt-free diet noncompliance was high in both groups; drug noncompliance was significantly higher in patients with myocardial infarction. Angiotensin 11 receptor blocker use was associated significantly with myocardial infarction more than in stroke.
Related Concept Videos
Ischemic Stroke l: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Hemorrhagic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Stroke: Introduction and Types
